Stryker (SYK) Form 144: Planned Sale of 165 Shares Filed

Stryker Corp has a Form 144 notice indicating a planned sale of 165 shares of common stock through UBS Financial Services on the NYSE, with an aggregate market value of 60370.

Accepted by SEC EDGAR 11/20/2025 - 12:03 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Stryker Corp has a Form 144 notice indicating a planned sale of 165 shares of common stock through UBS Financial Services on the NYSE, with an aggregate market value of 60370. The approximate sale date listed is 11/20/2025.

The shares to be sold were acquired on 03/21/2025 via RSU vesting, with payment made by wire the same day. Shares outstanding were 382,164,865 as of the figure shown, which serves as a baseline for the issuer’s total equity.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does this Form 144 filing mean for Stryker (SYK)?

The Form 144 shows a person related to Stryker Corp plans to sell 165 shares of common stock on the NYSE through UBS Financial Services, subject to Rule 144 conditions.

How many Stryker (SYK) shares are being sold under this Form 144?

The notice covers a planned sale of 165 shares of Stryker common stock, with an aggregate market value of 60370 at the time referenced.

When were the Stryker (SYK) shares to be sold acquired?

The 165 shares were acquired on 03/21/2025 through RSU vesting from Stryker Corp, with payment made by wire on the same date.

On which exchange will the Stryker (SYK) shares be sold and through which broker?

The planned sale is listed for the NYSE, using UBS Financial Services Inc. as the broker, with an address in Weehawken, New Jersey.

How many Stryker (SYK) shares were outstanding compared to this Form 144 sale?

The filing shows 382,164,865 shares of Stryker common stock outstanding, providing context for the 165-share planned sale.

What representation does the seller make in this Stryker (SYK) Form 144?

By signing, the seller represents that they do not know any material adverse information about Stryker’s current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002063939
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Stryker Corporation
SEC File Number	001-13149
Address of Issuer	1941 Stryker Way Portage MICHIGAN 49002
Phone	2693852600
Name of Person for Whose Account the Securities are To Be Sold	Preston Wells
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	165	60370	382164865	11/20/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/21/2025	RSU Vesting	Stryker Corp			165	03/21/2025	Wire

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	11/20/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/JOSEPH CASSIDY, for UBS Financial Services Inc, as attorney-in-fact for Preston Wells
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)